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Background: Human peroxidasin 1 (hsPxd01) mediates the formation of sulfilimine cross-links within the collagen IV
scaffold of basement membranes.
Results:Overexpressed hsPxd01 contains covalently linked heme catalytically active for production of hypobromous acid.
Conclusion: hsPxd01 has peroxidase-like active site structure but restricted substrate accessibility.
Significance: Architecture of hsPxd01 facilitates product release and its interactions with the physiological substrate collagen IV.
Human peroxidasin 1 (hsPxd01) is a multidomain heme per-
oxidase that uses bromide as a cofactor for the formation of
sulfilimine cross-links. The latter confers critical structural
reinforcement to collagen IV scaffolds. Here, hsPxd01 and var-
ious truncated variants lacking nonenzymatic domains were
recombinantly expressed inHEK cell lines. TheN-glycosylation
site occupancy and disulfide pattern, the oligomeric structure,
and unfolding pathway are reported. The homotrimeric iron
protein contains a covalently bound ferric high spin heme per
subunit with a standard reduction potential of the Fe(III)/Fe(II)
couple of233 5mVat pH7.0.Despite sequence homology at
the active site and biophysical properties similar to human per-
oxidases, the catalytic efficiency of bromide oxidation (kcat/
KMapp) of full-length hsPxd01 is rather low but increased upon
truncation. This is discussed with respect to its structure and
proposed biosynthetic function in collagen IV cross-linking.
Heme peroxidases are versatile enzymes abundant in all
kingdoms of life necessary formanifold physiological functions.
Several superfamilies and families have been described that
evolved independently during evolution. Chordata peroxidases
like myeloperoxidase (MPO),3 eosinophil peroxidase (EPO),
lactoperoxidase (LPO), and thyroid peroxidase (TPO) have
been shown to play important roles in innate immunity as
well as hormone biosynthesis (1, 2). Recently, a phylogenetic
study demonstrated that these vertebrate enzymes are part
of a superfamily that is composed of seven subfamilies (3). In
a close phylogenetic neighborhood of the above-mentioned
chordata peroxidases (i.e. subfamily 1), multidomain peroxi-
dases called peroxidasins are clustering in subfamily 2. This
name was first coined in 1994 by Nelson et al. (4), who suc-
ceeded in identifying the first representative in Drosophila
melanogaster. They described this peroxidasin as a multido-
main peroxidase that participates in extracellular matrix
consolidation. In the following 15 years, only a few papers
were published reporting the occurrence of peroxidasins in
other organisms like Caenorhabditis elegans (5) or Xenopus
tropicalis (6) and suggesting a role in extracellular matrix
biosynthesis. Finally, in 2008, the two human peroxidasins
(hsPxd01 and hsPxd02) became the focus of investigations
analyzing expression patterns (7–10) and biochemical prop-
erties (7, 8, 11, 12).
Great attention was devoted to human peroxidasin 1 after
publication of the work by Bhave et al. (13) that demonstrated
the responsibility of hsPxd01 for the formation of sulfilimine
bonds in collagen IV via release of hypohalous acids. Further-
more, it was shown that this unique covalent bond in basement
membrane is a primordial innovation for tissue evolution (14).
Moreover, very recently it could be demonstrated that bromide
oxidation to hypobromous acid mediated by hsPxd01 is essen-
tial for the assembly of collagen IV scaffolds in tissue develop-
ment and architecture (15).
Fig. 1 depicts themultidomain structure of human peroxida-
sin 1. Gene analysis shows the occurrence of a signal peptide,
one leucine-rich repeat domain (LRR), four immunoglobulin-
like motifs (Ig), a peroxidase domain (POX), and a C-terminal
vonWillebrand factorCdomain (VWC).Despite the important
physiological implications, no detailed structural information
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about human peroxidasin 1 is available. This prompted us to
study the biophysical and biochemical characteristics of human
peroxidasin 1 for a better understanding of itsmode of function
and mechanism.
EXPERIMENTAL PROCEDURES
Materials and Reagents—Ammonium bicarbonate, formic
acid, methanol, and acetonitrile were from Merck. 2,2,2-Tri-
fluoroethanol, iodoacetamide, trypsin (from bovine pancreas
and treated with L-1-tosylamide-2-phenylethyl chloromethyl
ketone), pepsin, and PNGase F (from Elizabethkingia meningo-
septica) were from Sigma. Water was purified using a Milli-Q
purification system (Millipore, Bedford, MA).
Three-dimensional StructuralModels of hsPxd01 Domains—
Models of distinct human peroxidasin 1 domains were gener-
ated using the ESyPred3D server (16). Amino acid identities of
the hsPxd01 domains with the respective templates of LRR
(PDB code 2O6S), Ig (PDB code 3B43), POX (PDB code 2R5L),
andVWC (PDB code 1U5M) domainswere 31.8, 21.1, 39.7, and
30.7%, respectively.
Cloning, Stable Transfection, Expression, and Purification of
hsPxd01—Full-length human peroxidasin 1 encoded on a
pcDNATM3.1/V5-His TOPO vector was kindly provided by
Miklo´s Geiszt (Department of Physiology, SemmelweisUniver-
sity School of Medicine, Budapest, Hungary). For the stable cal-
cium phosphate transfection of HEK 293 cells, standard selection
and cultivation procedures with minor modifications were used
(17). After screening of the stably transfected clones by immuno-
blotting as well as peroxidase activity screening, the best producer
was selected for large scale production in triple flasks (Life Tech-
nologies).Duringproduction, cellswere cultivated inDMEMsup-
plementedwith 10% fetal bovine serum, 5g/ml hematin, penicil-
lin, and streptomycin and a protease inhibitor mixture (Sigma).
The harvested media were stored at 4 °C and eventually purified
using immobilized metal affinity chromatography. Therefore, the
harvested media were supplemented with 300 mM NaCl, 40 mM
imidazole, andpHadjusted to 7.4 before applicationonto a chelat-
ing Sepharose gel column (GE Healthcare). The column was
chargedwithNi2 and equilibratedwith 20mMphosphate buffer,
pH 7.4, with 300 mM NaCl and 40 mM imidazole. Protein was
FIGURE 1.Arrangement and composition of domains of hsPxd01. A,models are of the following: (i) LRR domain, including N- and C-terminal capping
motifs; (ii) four consecutive Ig domains; (iii) VWC domain with highlighted cysteines; and (iv) of the peroxidase domain. The latter model was con-
structed using homologous goat LPO (PDB code 2R5L) as template. Magnified overlay of the active site of goat LPO(gLPO) and hsPxd01 illustrates the
conservation of all amino acids in the active site. Numbers in blue correspond to hsPxd01 amino acid sequence, including the signal peptide, and
numbers in pink correspond to gLPO amino acid sequence with (in parentheses) and without signal and propeptide region. B, domain arrangement of
human peroxidasin 1.
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elutedwith 20mMphosphate buffer containing 500mMNaCl and
300 mM imidazole. Fractions with the best purity number were
pooled, concentrated, and desalted using Centricon with a 100-
kDa cutoff membrane (Millipore).
Cloning, Transient Transfection, and Expression of hsPxd01
and Truncated Constructs—DNA of hsPxd01 and its truncated
versions were cloned into a modified pTT5 vector (NRC-BRI)
containing a C-terminal Strep tag to facilitate purification. Six
different constructs were designed and cloned, including the
complete protein hsPxd01-con1 (LRR-Ig-POX-VWC, 1453
amino acids), hsPxd01-con2 omitting the LRR domain (Ig-
POX-VWC, 1234 amino acids), hsPxd01-con3 excluding the
C-terminal VWC domain (LRR-Ig-POX, 1288 amino acids),
and hsPxd01-con4 omits both domains (Ig-POX, 1069 amino
acids). hsPxd01-con5 (695 amino acids) and hsPxd01-con6
(593 amino acids) consist only of the peroxidase domain,
including or excluding the homologous propeptide region,
respectively. The forward and reverse primers used for the
construct preparations were as follows: 5-ATGCG-
CTAGCGTGGTGGCCCAGAAGCCGGGCGCAGGGTGT-
CCG-3 and 5-ATGCGGTACCGGGCTTTTCCTCCG-
CCCTCTTCTGTAAGCAGACTGG-3 for hsPxd01-con1;
5-ATGCGCTAGCCCCCGGATCACCTCCGAGCCCCAG-
GACGCAGATGTGACC-3 and 5-ATGCGGTACCGGGC-
TTTTCCTCCGCCCTCTTCTGTAAGCAGACTGG-3 for
hsPxd01-con2; 5-ATGCGCTAGCGTGGTGGCCCAGAAG-
CCGGGCGCAGGGTGTCCG-3 and 5-ATGCGGTACCG-
TCCTGCCACACCCGGAGGTCCACCCTGGGG-3; 5-
ATGCGCTAGCCCCCGGATCACCTCCGAGCCCCAGGA-
CGCAGATGTGACC-3 and 5-ATGCGGTACCGTCCTGC-
GGG-3; 5-ATGCGCTAGCGGAGATCCGTTTGTAGCTA-
CCTCCATCGTGG-3 and 5-ATGCGGTACCGTCCTGCC-
ACACCCGGAGGTCCACCCTGGGG-3; and 5-ATGCG-
CTAGCGGCTGTACCGCCCACCGGCGCGTGAACAAC-
TGC-3 and 5-ATGCGGTACCGTCCTGCCACACCCGGA-
GGTCCACCCTGGGG-3 for constructs 3–6, respectively.
For the determination of the thermal stability and bromination
activity as described below, a hsPxd01-con4 versionwithN-ter-
minal polyhistidine tag for easy purification andHRV-3C cleav-
age site for tag removal was used. The following two primers
were employed for PCR amplification: 5-ATGCGCTAGCCA-
TCATCACCATCACCATCACCATCTGGAAGTACTTTT-
TCAGGGGCCCCCCCGGATCACCTCCGAGCCCCAGGA-
CGCAGATGTGACC-3 and 5-ATGCGCGGCCGCTTA-
TCAATGGTGATGGTGATGATGGTCCTGCCACACCC-
GGAGGTCCACCCTGGGG-3. Themeasurementswere con-
ducted without prior polyhistidine tag removal. The plasmid
preparation as well as PCR and restriction screening were car-
ried out in Escherichia coli TOP10 cells. Before endotoxin-free
maxi preparation of plasmid DNA (Qiagen, Macherey-Nagel)
for transient transfection, the respective constructs were vali-
dated by DNA sequencing. HEK 293 6E cells (NRC-BRI) were
cultivated as described previously (18, 19) using F17media (Life
Sciences) with 0.1% pluronic F68 agent (Gibco), 4 mM L-gluta-
mine (Gibco) and 50 g/ml geneticin. For transfection, stand-
ard procedures for the recombinant production of secreted
proteins were followed with minor variations. For varying
cell culture volumes, the procedures were scaled up or
down accordingly. To improve heme incorporation into the
peroxidase domain, 5 g/ml hematin was added 4 h
post-transfection. Cell supernatant was harvested 5 days
post-transfection.
SDS-PAGE, Western Blot, and Multiangle Light Scattering—
Protein samples were separated by gradient PAGE and ana-
lyzed either directly using Coomassie Blue staining or after
immunoblotting onto a nitrocellulose membrane (GE Health-
care) using anti-His (Qiagen), anti-Strep (IBA), or anti-hsPxd01
antibodies (Sigma). Standard protocols were followed.
For determination of the molar mass, the protein samples
were analyzed by SEC chromatography coupled to detectors for
analysis of UV-visible, refraction index, and multiangle light
scattering (MALS). For instrumentation, HPLC (Shimadzu
prominence LC20) and MALS (WYATT Helios Dawn8 plus
QELS; software ASTRA 6) were used, and the columns were
WYATT SEC Columns (7.8 5 and 7.8 mm 300 mm; parti-
cle size, 5 m, pore size 300 Å) with corresponding guard col-
umn (WTC030S5G). SEC buffer was Dulbecco’s PBS plus 200
mMNaCl; flow rate was 0.5 ml per min; injected protein was 55
g. For performance of SEC chromatography under reducing
conditions, the protein was pretreated with 50 mM dithiothre-
itol (DTT) for 30 min at room temperature, and during chro-
matography, the SEC buffer contained 2 mM DTT.
Assessment of Heme to Protein Linkage by Enhanced Chemi-
luminescence (ECL)—MPO and hsPxd01 samples were heated
for 10 min at 70 °C before separation by gradient PAGE. Then
the gel was blotted on nitrocellulose membrane, and the cova-
lent heme to protein was probed by ECL detection (20). Clarity
Western ECL (Bio-Rad) substrate was used as recommended,
and signals were detected with a ChemiDoc XRS imaging
system (Bio-Rad).
Mass Spectrometric Analysis of Glycosylation Occupancy—
After precipitation by 10% trichloroacetic acid, recombinant
hsPxd01 pellets were dissolved in the denaturation buffer
ammonium bicarbonate (100 mM) and 2,2,2-trifluoroethanol
and subsequently reduced by DTT. Alkylation was performed
with iodoacetamide, and the excess was quenched again by
DTT. Before addition of trypsin or pepsin, the sample was
diluted 10 times, and the pHwas adjusted to the corresponding
optimum. After overnight incubation at 37 °C, the proteases
were heat-inactivated. Finally, PNGase F was added and incu-
bated overnight at 37 °C.
For N-glycan site occupancy, a rapid resolution liquid chro-
matographic system (1200 series) coupled to a quadrupole/
time-of-flight equipped with an electrospray ionization source
(ESI-QTOF 6520 series) mass spectrometer (Agilent Technol-
ogies, Palo Alto, CA) was used for analysis of the aforemen-
tioned protein digests (21). As PNGase F removes glycans and
performs deamination of asparagine (Asn3Asp), the glycosyl-
ation occupancywas calculated bymeasuring the ratio between
the area under the curve of the native peptide and its deami-
nated form. Total occupancy (100%) was obtained when the
deaminated form of the peptide alone was detected. A glycosyl-
ation site free of glycans (0% of occupancy) was obtained when
only the peptide with the native Asn residue was present. For
prediction of glycosylation sites NetNgly was used (22).
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Mass Spectrometric Analysis of Cysteines and Cystines—
Analysis of cysteine residues was carried out on hsPxd01
according to a method previously described for sequence
recovery (23). The method was adjusted to allow for the recov-
ery of free cysteines as carbamidomethylated cysteines,
whereas disulfide bonds were conserved. Briefly, recombinant
hsPxd01 (350g) was incubated at 20 °C in darkness for 10 h in
25 l of 100 mM ammonium bicarbonate, including 60 mM
iodoacetamide. 25l of 2,2,2-trifluoroethanol, 300l of formic
acid (2% (v/v) inwater), and 300l of pepsin (5mg/ml in formic
acid 2% (v/v) in water) were added, and hsPxd01 was digested
overnight at 37 °C. After pepsin heat inactivation, pH was
adjusted to 7–8, and PNGase F (100 milliunits) was added to
proceed to peptide deglycosylation for 7 h at 37 °C. Finally,
trypsin (50l, 1mg/ml)was added, and overnight digestionwas
performed at 37 °C. Trypsin was inactivated by addition of 2 l
of formic acid (100% (v/v)), and sample was dried down using a
centrifuge vacuum. Sample was finally dissolved in 200 l of
formic acid (0.1% (v/v) in water). Free cysteines are detected in
an alkylated form (carbamidocysteine).
30 l of the resulting samples were injected into the LC sys-
tem and analyzed as described previously (23). Briefly, analyses
were performed with the rapid resolution liquid chromato-
graphic ESI-QTOF system described above. Peptides were sep-
arated on a Poroshell-120 end-capped C18 (100  2.1 mm
inner diameter, 2.7-m particle size) from Agilent Technolo-
gies (PaloAlto, CA) using a 105-min gradient of formic acid and
acetonitrile (23). Auto-MS/MS spectra were acquired in posi-
tive and high resolution acquisition mode (4 GHz) (23). Data
were acquired by the Mass Hunter Acquisition for TOF and
QTOF (version B.04 SP3) software and analyzed by the Mass
Hunter Qualitative Analysis (version B.05 SP1) with Biocon-
firm and by Spectrum Mill software (Agilent Technologies,
Palo Alto, CA).
Electron Paramagnetic Resonance Spectroscopy (EPR)—Puri-
fied recombinant hsPxd01 and hsPxd01-con4 were prepared in
40mMcitrate/phosphate buffer, pH7, and 20%glycerol (Sigma)
as cryoprotectant. The sample was transferred into Wilmad
quartz tubes (3 mm inner diameter) and flash-frozen in liquid
N2. Frozen samples were kept frozen on dry ice while the head-
space above the sample was flushed with argon. Oxygen-free
samples were frozen back to 77 K and transferred into the res-
onator for 10 K measurements. Spectra were recorded on a
Bruker EMX continuous wave EPR spectrometer, operating at
X-band (9 GHz) frequencies, equipped with a high sensitivity
resonator and an Oxford Instruments ESR900 cryostat. EPR
spectra were recorded under nonsaturating conditions using 2
milliwatts microwave power, 100 kHzmodulation frequency, 1
millitesla modulation amplitude, 41-ms conversion time,
41-ms time constant, and 2048 points. Simulation of high spin
Fe(III) forms was carried out using the software EasySpin (24)
and consisted of aweighted sumof simulations of the individual
high spin compounds. The rhombicity was obtained from gxeff
and gyeff (25), and the relative intensities were calculated on the
basis of the simulations.
Spectroelectrochemistry—The standard reduction potential,
E0, determination was performed using a homemade optically
transparent thin layer spectroelectrochemical cell (26–28).
Spectroelectrochemical titrations were carried out at 25 °C
using 1-ml samples containing 5 M hsPxd01 or hsPxd01-con4
dissolved in 100 mM phosphate buffer and 100 mM NaCl, pH
7.4, in the presence of 30 M methyl viologen and 1 M lumi-
flavine 3-acetate, methylene blue, phenazine methosulfate, and
indigo disulfonate as mediators.
Determination of Thermal Stability—Temperature-medi-
ated protein unfolding was followed either by electronic circu-
lar dichroism (ECD) spectroscopy or differential scanning
calorimetry (DSC). For ECD, Chirascan from Applied Photo-
physics (Leatherhead, UK) was used, and changes of the ellip-
ticity at 208 nm as well as at 412 nm in 20mM phosphate buffer,
pH 7.4, with increasing temperature were recorded and evalu-
ated (29). The instrument was flushed with nitrogen at a flow
rate of 5 liters min1 and was equipped with a Peltier element
for temperature control. Temperature-mediated denaturation
was monitored between 20 and 95 °C. Temperature was
increased stepwise with 1.0 °C min1. Single wavelength scans
were performed with instrumental parameters set as follows.
Visible ECD at Soret maximum was performed with 9.5 M
hsPxd01 in 20 mM phosphate buffer, pH 7.4. The path length
was 10 mm and spectral bandwidth 1 nm, and scan time per
point was set at 10 s. Far-UV ECD at 208 nm was performed
with 4.8 M hsPxd01 in 20 mM phosphate buffer, pH 7.4. The
path length was 1 mm and spectral bandwidth 3 nm, and scan
time per point was set at 10 s.
DSC analysis was done with a VP-DSC Capillary Cell Micro-
calorimeter (MicroCal). 5 M protein samples in 20 mM phos-
phate buffer, pH 7.4, were heated from 30 to 100 °C with a
heating rate of 1 °C min1. Baselines were subtracted and data
normalized for protein concentration and fitted with a non-
two-state thermal unfoldingmodel using the softwareOrigin 7.
Determination of Bromination Activity—Bromination activ-
ity of recombinant hsPxd01 and hsPxd01-con4was tested spec-
trophotometrically by measuring the halogenation of NADH.
The produced hypobromous acid reacts with NADH to stable
bromohydrin. This assay detects the initial rate of bromohydrin
production at  275 nm using 275 of 11,800 M1 cm1 (30–
32). Bromide was chosen because it was shown to be an essen-
tial trace element for assembly of collagen IV scaffolds in tissue
development and architecture (15). Briefly, 100 nM hsPxd01 or
hsPxd01-con4 was incubated at 25 °C in 20 mM phosphate
buffer, pH 7.4, containing 100 M NADH and varying concen-
trations of either hydrogenperoxide (with a constantNaBr con-
centration of 5 mM) or NaBr (with a constant hydrogen perox-
ide concentration of 50 M) (32). Reactions were started upon
addition of H2O2. Initial rates were measured over the 1st min
of reaction to minimize possible inhibition by hydrogen perox-
ide. Note that Michaelis-Menten parameters (Km and Vmax)
derived from steady-state rate measurements do not conform
to reactions catalyzed by peroxidases, which follow an irrevers-
ible ping-pongmechanism (where equilibria between reactants
and products are not established). Nevertheless, to allow the
comparison of the bromination activity of hsPxd01 with data
from peroxidases investigated under the same assay conditions
(32) and to keep the kinetic model as simple as possible, we
present KMapp and Vmaxapp values, which were determined using
nonlinear regression (Sigma Plot, Jandel Scientific). Here, the
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KMapp value simply represents the substrate concentrationwhere
the overall rate is half of its maximum value, and theVmaxapp value
represents the limiting step of the overall reaction at certain
enzyme and substrate concentrations. Importantly, no reaction
was observed upon mixing of only NADH, hydrogen peroxide,
and hsPxd01 or hsPxd01-con4.
RESULTS
Properties of Recombinant Protein and Oligomeric
Structure—The average yield of recombinant hsPxd01 pro-
duced in HEK 293 cells by stable transfection was 0.5–0.9 mg
per liter of harvestedmedia. Recombinant humanperoxidasin 1
(hsPxd01) either produced by stable or transient transfection
applied to SDS-PAGE had a molar mass of500 kDa (Fig. 2A,
lanes 1–3). The theoretical molar mass of the protein (1445
amino acids without signal peptide, see also Fig. 5) is 163 kDa.
Under reducing conditions, the protein band is found at180
kDa (Fig. 2A, lanes 4–6), suggesting that hsPxd01 is an oligo-
meric protein with monomers being linked by DTT-sensitive
covalent bonds. The gels were stained with anti-hsPxd01 anti-
body (Fig. 2A, lanes 1 and 4), anti-His antibody (lanes 2 and 5),
and Coomassie Blue (lanes 3 and 6).
FIGURE 2. Structural and spectral properties of human peroxidasin 1. A, SDS-PAGE (3–8% gradient polyacrylamide) of hsPxd01 purified from stably
transfected HEK 293 cells under nonreducing (left panel) and reducing conditions (right panel). The gel was stained with anti-Pxd antibody (lanes 1 and 4),
anti-His antibody (lanes 2 and 5), and Coomassie Blue (lanes 3 and 6). B, far-UV CD spectrum of 4.8M recombinant hsPxd01 (20mM phosphate buffer, pH 7.4).
Additionally, the calculated overall secondary structure composition is depicted. C, UV-visible spectrum of 9.5 M recombinant hsPxd01 in 20 mM phosphate
buffer, pH 7.4. The inset shows the corresponding CD spectrum in the visible region. D, covalent heme to protein linkage detected by enhanced chemilumi-
nescence under nonreducing conditions with heated samples of full-length hsPxd01 (lane 1) and hMPO (lane 2). E, representative experimental EPR spectrum
(black line) of 20 M hsPxd01 at 10 K (40 mM citrate/phosphate buffer, pH 7, 20% glycerol) using 30 scans. The simulated spectrum (red line) as sum of three
individual high spin species clearly indicates ligand coordination of axial symmetry. The simulation parameters of these high spin forms used for simulation as
well as the minor contribution (%) from rhombic ligand coordination are also shown.
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The far-UV ECD spectrum of recombinant hsPxd01 showed
a clear minimum at 208 nm as well as a shoulder at 220 nm and
a maximum around 195 nm corresponding to an overall sec-
ondary structure composition of 41% -helices and 30%
-sheets (Fig. 2B). Purified recombinant hsPxd01 had a Soret
band at 410 nm and additional bands at 529, 563, and 627 nm.
Very similar spectra were obtained for the construct
hsPxd01-con4 (data not shown). The average Reinheitszahl
(purity number, i.e. A410 nm/A280 nm) of hsPxd01 varied
between 0.41 and 0.47 corresponding to 72–81% heme occu-
pancy. Molar extinction coefficients at 280 and 410 nm using
the Bradford protein assay were determined to be 163,000
and 89,000 M1 cm1, respectively. The spectrum of a rep-
resentative preparation is depicted in Fig. 2C. The ECD spec-
trum in the visible region shows a minimum at 396 nm and a
maximum at 412 nm (inset to Fig. 2C). The heme in hsPxd01
(as well as in the constructs) is covalently linked as demon-
strated in Fig. 2D. Continuous wave low temperature EPR
spectra of hsPxd01 at pH 7 demonstrates the presence of
mostly high spin Fe(III). Fig. 2E depicts a representative
experimental spectrum of 20 M hsPxd01 as well as the sim-
ulated spectrum (red line) as sum of individual high spin
species clearly indicating ligand coordination of axial sym-
metry. A similar high spin Fe(III) spectrumwas also obtained
with hsPxd01-con4 (data not shown). Depending on the pro-
tein batch, a minor contribution of low spin species was
observed in both proteins.
To obtain the exactmolarmass and oligomeric composition,
purified recombinant hsPxd01 was analyzed by HPLC com-
bined with UV-visible, refraction index, and MALS detectors.
Fig. 3A shows that the protein eluted as a single peak at a reten-
tion time of 14.35min.With SEC-MALS, an average size of 504
kDa was obtained, which is in accordance with a homotrimeric
structure (Fig. 3B). When SEC was performed under reducing
conditions, the most prominent peak eluted at 18.54 min with
an average size of 175 kDa. These data clearly demonstrate that
this humanmultidomain peroxidase is a homotrimeric and gly-
cosylated protein. Glycosylation contributes with about 12 kDa
to the total molar mass of hsPxd01.
Next, we were interested in which domains were involved in
the covalent linkage between the three monomers. Different
(truncated) constructs were designed (summarized in Fig. 4A)
and transiently expressed in HEK 293 6E cells. Briefly, besides
the complete protein (hsPxd01) variants without the VWC
domain (hsPxd01-con3), without LRR and VWC domains
(hsPxd01-con4), without LRR, Ig, and VWC domains
(hsPxd01-con5), and without LRR, Ig and VWC domains and
the propeptideN-terminal of the peroxidase domain (hsPxd01-
con6) were produced (Fig. 4B). The media of small scale exper-
iments were harvested and directly applied to SDS-PAGE
without any further purification step. Under nonreducing con-
ditions the presence of trimeric hsPxd01 was visible, whereas
hsPxd01-con3, hsPxd01-con4, and hsPxd01-con5 are mono-
meric (compare upper panels (Coomassie Blue staining) with
lower panels (immunoblotting) in Fig. 4B). Under reducing
conditions a similar pattern was obtained except for the full-
length protein, which now gave a band at 180 kDa. In the case of
hsPxd01-con6, various bands at a higher molar mass range
appeared indicating instability and aggregation. Because the
yield of this construct was poor compared with the other con-
structs, this might indicate that the homologous propeptide
region contributed to the conformational stability. However,
themain conclusion from these data is that in the absence of the
VWC domain the constructs weremonomeric, clearly suggest-
ing that hsPxd01 is a homotrimeric protein having the mono-
mers covalently linked by disulfide bridges between their C-ter-
minal VWC domains.
N-Glycosylation Site Occupancy and Disulfide Pattern of
Human Peroxidasin 1—Computationally, 11 N-glycosylation
sites were predicted for hsPxd01 (Fig. 5). The first one (Asn-
390) was located at the second Ig domain on the loop between
the C- and D-strand (similar to CH2 glycosylation in IgG1-Fc).
In the peroxidase domain seven NX(S/T) motifs were found,
four in propeptide region (Asn-640, Asn-699, Asn-719, and
Asn-731) and four in the core of the peroxidase domain (Asn-
865, Asn-964, Asn-1178, and Asn-1280). Two furtherN-glyco-
sylation sites were predicted to be at the linker between the
peroxidase domain and the VWCdomain (Asn-1368) as well as
on the VWCmodule itself (Asn-1425) (Fig. 5).
For experimental verification, hsPxd01 was proteolytically
cleaved by either pepsin or trypsin, deglycosylated using
PNGase F, and analyzed by mass spectrometry. Table 1 pres-
ents a detailed list of identified peptides and their glycosylation
status. Glycosylation occupancy was assessed by deamination
of asparagines (Asn3Asp) due to glycan removal by PNGase F.
Data demonstrate that except for Asn-964, all other sites
wereN-glycosylated, four completely (Asn-640, Asn-731, Asn-
865, and Asn-1425), whereas the others were found partially
glycosylated. Table 1 depicts the relative occupancy in both
digests. For example, more than 70% of the recovered peptides
at Asn-390, Asn-699, Asn-1178, and Asn-1280 were glycosy-
lated, whereas Asn-719 was mostly nonglycosylated (peptic
digest, 100%; tryptic digest, 86.59%).
Furthermore, we analyzed which cysteines are involved in
disulfide bridges. Mass spectrometric analysis of recombinant
hsPxd01 demonstrated that Cys-12 and Cys-20 (signal pep-
tide), Cys-736 andCys-970 (peroxidase domain), andCys-1315,
Cys-1316, and Cys-1319 (VWC domain) are free cysteines as
demonstrated by the presence of alkylation (Table 2). This sug-
gests that the other cysteines are involved in disulfide bond
formation as has been proposed by Uniprot (33). From the 20
predicted bound cysteines, 12 could be confirmed byMS. Con-
firmed disulfide bridges include Cys-36–Cys-42, Cys-40–Cys-
49, Cys-196–Cys-243, and Cys-198–Cys-222 (LRR domains),
Cys-267–Cys-317 and Cys-454–Cys-502 (IgG domains), Cys-
620–Cys-721 (propeptide region of peroxidase domain), and
Cys-723–Cys-885, Cys-732–Cys-748, Cys-847–Cys-857, Cys-
851–Cys-875, Cys-1177–Cys-1234, and Cys-1275–Cys-1301
(peroxidase domain) (Table 2). Eight predicted disulfide
bridges could not be found, two in the IgG-like domains, one in
the peroxidase domain, and five in the VWCdomain. This does
notmean that they are not present because during sample prep-
aration bond breakage and subsequent alkylation might occur
(this was also partially observed with the verified disulfide
bridges). Additionally, the sequence alignment of the four IgG-
like domains suggests the existence of one disulfide bridge per
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-barrel structure. Regarding the proposed cystines in the
VWCdomain it has to bementioned that its sequence recovery
was poor, which might explain that the respective peptides
were not found. In general, due to the complex sequence of
hsPxd01, attaining a good sequence mapping is quite challeng-
ing because the obtained peptides were either rather big or very
small. This was the reason for using both pepsin and trypsin in
a sequential manner.
Heme Cavity Architecture—To gain further insight into the
heme cavity architecture of hsPxd01, we probed its redox prop-
erties by spectroelectrochemistry. This allowed the comparison
of peroxidasin 1 with other mammalian peroxidases (MPO,
LPO, and EPO) and a prediction of the catalytic ability of the
enzyme especially regarding the oxidation of halides (Cl 	
Br 	 I). Fig. 6A shows the spectral transition upon electro-
chemical reduction of ferric to ferrous hsPxd01 at pH 7.4 and
25 °C. There was a clear direct transition to ferrous hsPxd01
with a Soret maximum at 420 nm and additional bands at 523
and 553 nm and isosbestic points at 413 and 510 nm. The slope
of the corresponding Nernst plot (Fig. 6B) is close to the theo-
retical value for a redox equilibrium involving the exchange of a
single electron. The reduction potential of the Fe(III)/Fe(II)
couple at pH 7.4 and 25 °C was calculated to be233
 5 mV,
which is more negative than that reported for bovine LPO
FIGURE 3. Oligomeric structure of human peroxidasin 1. A, SEC of recombinant hsPxd01. The inset depicts the UV-visible spectrum of the fraction
eluting at 14.5 min. B, comparison of SECs of hsPxd01 obtained under nonreducing and reducing conditions (dotted line). Representative peak analyses
usingMALS (software ASTRA) are shown, including the calculatedmolar masses of the trimeric andmonomeric states of hsPxd01.mAU, milliabsorbance
units.
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(i.e.176 to190mV) (28, 34) or humanMPO (5mV) (27). In
case of the construct hsPxd01-con4, the corresponding E0
value was determined to be215
 10 mV.
Thermal Stability and Bromination Activity of Human Per-
oxidasin 1—Both ECDandDSCwere used to probe the thermal
stability of the full-length protein as well as hsPxd01-con4 (Fig.
7). These complementary methods allow determination of the
unfolding pathway of this multidomain protein. They provide
crucial information about stability of and cross-talk between
the individual domains of hsPxd01, which might be important
for understanding the interaction with its physiological reac-
tion partner(s).
The loss of secondary structure at 208 nmby ECD shows that
significant loss of ellipticity already starts around 40 °C and
ends around 70 °C suggesting a multistep noncooperative
unfolding pathway (Fig. 7A). By contrast, the ellipticity at the
heme Soret band at 412 nm (reflecting unfolding events in the
heme cavity of the peroxidase domain) changed within 45 and
60 °C (estimated Tm at 52.2 °C) (Fig. 7B).
To getmore detailed information about the unfolding pathway
of hsPxd01 and hsPxd01-con4 (Ig-Ig-Ig-Ig-POX), DSC experi-
ments were performed (Fig. 7,C andD). The thermogram of full-
lengthhsPxd01 is complex and is best fittedby the assumptionof a
noncooperative (non-two-state or multiple state) transition that
includes four distinct unfolding steps. Best fitting is obtained with
four endotherms with Tm values of 51.5, 61.1, 69.1, and 77.5 °C,
respectively. Because ellipticity in the heme region is lost between
46 and 60 °C (Fig. 7B), it is reasonable to assume that the peroxi-
dase domain has the lowest thermal stability of this multidomain
protein with a Tm value at51–52 °C.
Fig. 7D shows the thermogram of hsPxd01-con4 fitted with a
noncooperative (non-two-state) transition of two distinct
unfolding steps. The obtained Tm values are 55.5 and 67.8 °C,
thereby substantiating the peroxidase domain of hsPxd01 as the
domain with the lowest melting point and identifying the Tm
value of the Ig domain around 68 °C.
Finally, the enzymatic activity of hsPxd01 and hsPxd01-con4
was probed (Fig. 8). The few available publications about the
FIGURE 4. SDS-PAGE of human peroxidasin 1 and four (truncated) constructs under nonreducing and reducing conditions. A, hsPxd01 is full-length
protein; hsPxd01-con3 lacks the VWC domain; hsPxd01-con4 lacks LRR and VWC domains; hsPxd01-con5 represents the peroxidase domain only including the
“propeptide region”; hsPxd01-con6 represents the peroxidase domain without the “propeptide region.” Additionally, the molar masses of the respective
(unglycosylated)proteins in themonomeric and (putative) trimeric states arepresented.B,electrophoresis of recombinantproteinsproduced inHEK293E cells
under denaturating and either nonreducing (left panels) or reducing (right panels) conditions. Gels were stained with Coomassie Blue (upper panels) as well as
immunoblotted and detected with anti-Strep antibody (lower panels).
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halogenation activity of human peroxidasin 1 (12, 13, 15) are
puzzling, because the reported activities are very low compared
with chordata peroxidases, including LPO, EPO, and MPO.
This observation is somehow contradictory to the high
sequence similarity and the presence of all essential amino acids
in the active site of subfamily 1 and 2 proteins (see also Figs. 1
and 5). Thus, to examine the kinetics of oxidation of bromide,
the effect on the initial rate of bromination of NADHwas mea-
sured at varying concentrations of bromide and hydrogen per-
oxide. This assay is very sensitive, and it allowed the detection
of apparent kinetic constants of both hsPxd01 and hsPxd01-
con4 (Fig. 8). Saturation kinetics behavior was observed in the
presence of 5mM bromide and varying hydrogen peroxide con-
centrations as well as in the presence of 50 M hydrogen per-
FIGURE 5.N-Glycosylation anddisulfidepattern of humanperoxidasin 1.A, schematic presentation of glycosylation sites of hsPxd01. B,multiple sequence
alignment (Clustal X, version 1.81) of hsPxd01 with human myeloperoxidase (hMPO) and lactoperoxidase from goat (gLPO). The respective propeptides of
hMPOandgoat LPO are underlined. Important catalytic residues are highlighted in blue, and amino acid residues forming the covalent linkswith the prosthetic
group are depicted in red. Cysteine residues are marked in gray, and cysteines involved in disulfide bonds (confirmed by MS spectrometry) are connected.
Glycosylation sites are highlighted in black, andpartially glycosylated residues of POX are shown in black andmarkedwith *. Oneputative not glycosylated site
on POX is boxed in black. Additionally, the distinct domains are marked by different coloring (signal peptide, gray; LRR, yellow; Ig, green; POX, blue; VWC, light
gray). Please note that the background highlight colors for different sections of the sequence alignment match the domain coloring indicated in the upper
panel.
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oxide and different bromide concentrations. The bromination
rate ofNADHdidnot dependonNADHconcentration andwas
entirely related to the rate of hypobromous acid production by
hsPxd01 and hsPxd01-con4 as reported in the literature (30,
31). Table 3 summarizes the apparent kinetic constants
KMapp, kcat, and kcat/KMapp obtained from these curves. Interest-
ingly, the KMapp values for both H2O2 and Br for hsPxd01 and
hsPxd01-con4 were similar (Table 3), whereas the kcat values of
hsPxd01-con4 were more than 15 times higher.
DISCUSSION
The interest in human peroxidasin 1 has increased rapidly
over the last years especially since the discovery of its essential
role in the formation of collagen IV cross-links (13, 15). It has
TABLE 1
Relative occupancy for the 10 N-glycan sites of recombinant human peroxidasin 1
For comparison, also see Fig. 5.
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been shown that the absence of the enzyme has severe and fatal
impacts in model organisms (5, 6, 15), but detrimental muta-
tions in humans have also been reported (35, 36). Therefore, a
better understanding of the biochemical function and biophys-
ical properties can be of crucial importance.
Sequence analysis of the multidomain subunit structure of
hsPxd01 suggested the occurrence of one enzymatic domain
with homology to mammalian peroxidases (3). Similar to the
latter, the heme in hsPxd01 is post-translationallymodified and
covalently linked to acidic amino acids (Asp-826 and Glu-980)
(3, 37). The proximal heme ligand histidine is likely hydrogen-
bonded to an asparagine, and at the distal heme cavity all cata-
lytic residues (His-827, Gln-823, and Arg-977) are found (3).
The His/Arg pair is involved in the heterolytic cleavage of
hydrogen peroxide during compound I formation, whereas the
glutamine residue is involved in the binding of halides (3). As a
consequence, the observed spectral (Soret band at 410 nm, high
spin ferric state) and redox properties of hsPxd01 are compa-
rable with LPO. The reduction potential of the Fe(III)/Fe(II)
couple of 233 
 5 mV is more negative compared with LPO
(i.e.176 to190mM) (28, 34), EPO (126mV) (28), orMPO
(5 mV) (27).
N-Glycosylation occupancy of the peroxidase domain of
hsPxd01 could be verified at seven positions. Thismatches with
five N-glycans in mature homodimeric MPO and pro-MPO
produced in CHO cell lines (21). Monomeric bovine lactoper-
oxidase has four N-glycosylation sites (38). Furthermore, the
peroxidase domain of hsPxd01 was shown to be stabilized by
seven confirmed disulfide bridges, including the propeptide
region. One predicted disulfide bond in the peroxidase domain
(Cys-959–Cys-970) could not be confirmed; however, there
was also no free Cys-959 detected. In hsPxd01, this region is
part of the polypeptide chain, whereas in mammalian peroxi-
dases (which have no additional domains), it is proteolytically
cleaved off duringmaturation. InMPO there are six intra-chain
disulfide bridges (and one between the two subunits), whereas
monomeric LPO is stabilized by seven cystines. Together with
the recently published phylogenetic studies (39), these findings
TABLE 2
Oxidation status of cysteines of recombinant human peroxidasin 1
The corresponding peptide sequences and MS details are given.
Cysteine status Peptide sequences and locations m/z Error
Peak height
(counts)
ppm
Alkylated cysteine (Cys12) 7GPGRRCL13 815.4291 1.7 99,640
Alkylated cysteine (Cys20) 17VLFCAW22 795.3889 4.3 10,731
Disulfide bond (Cys36–Cys42) 26AVVAQKPGAGCPSR39 40CLCF43 49CMHL52 581.5230 1.7 61,830
Disulfide bond (Cys40–Cys49)
Disulfide bond (Cys40–Cys49) 40CL41 45TTVRCMHL52 1192.5695 4.6 496,491
Disulfide bond (Cys196–Cys243) 195HCDCEILW202 242NCERPR247 222CEYPRRIQGR231 1532.6970 0.1 4715
Disulfide bond (Cys198–Cys222)
Disulfide bond (Cys267–Cys317) 265FTCR268 315YQCMAKNVAGEVK327 982.4679 4.5 4531
Disulfide bond (Cys454–Cys502) 453QCEAK457 495HDQGQYECQAVNII508 549.0033 9.9 260,843
Alkylated cysteine (Cys502) 501ECQAVNIIGSQK512 673.8504 7.2 833,089
Disulfide bond (Cys723–Cys885) 718ANLSGCTAHRRVNNCSDMCF737
881SSPVCGSGMTSLLMNSVYPREQI903
741YRTHDGTCNNL751
1189.7363 5.8 4632
Disulfide bond (Cys732–Cys748)
Alkylated cysteine (Cys736) 729VNNCSDMCF737 545.1964 4.9 49,406
Disulfide bond (Cys732–Cys748) 729VNNCSDMCF737
743THDGTCNNLQHPMWGASL760
1506.0912 9.6 4455
Disulfide bond (Cys847–Cys857) 842SDGQHCSNVCSNDPPCF858 875CMF877 1102.8999 13.9 24,306
Disulfide bond (Cys851–Cys875)
Alkylated cysteine (Cys970) 962DENESPIPCF971 403.1687 1.7 9367
Disulfide bond (Cys1177–Cys1234) 1177CNLSAAHTF1185 1229GPTLMCL1235 847.8858 3.4 5330
Alkylated cysteine (Cys1234) 1229GPTLMCL1235 791.3769 2.7 5841
Disulfide bond (Cys1275–Cys1301) 1273ILCDNADNI1281 1299GSCDEIPRVDLR1310 1174.0454 9.6 4376
Alkylated cysteine (Cys1275) 1273ILCDNADNI1281 524.2406 3.9 72,256
3 Alkylated cysteines (Cys1315, Cys1316, Cys1319) 1310RVWQDCCEDCR1320 528.5469 6.0 2449
Alkylated cysteine (Cys1415) 1410LSTTECVDAGGESHANNTKWK1430 577.0208 3.9 65,856
FIGURE 6. Spectroelectrochemistry of human peroxidasin 1. A, electronic spectra of hsPxd01 obtained at various potentials in spectroelectrochemical
experiments (100 mM phosphate buffer, pH 7.4, including 100 mM NaCl). B, corresponding Nernst plot is reported, where X represents ((Ared
max  Ared)/
(Aox
max Aox)) with ox 410 nm and red 420 nm, respectively.
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suggest a similar overall (mainly -helical) structure as well as
heme cavity architecture of the peroxidase domain of hsPxd01
(Fig. 5).
Besides the heavily glycosylated peroxidase domain, three
additional glycosylation positions could be verified at the sec-
ond immunoglobulin domain, the linker between the peroxi-
dase andVWCdomain aswell as at the vonWillebrand factorC
domain. Four intradomain cystines could be identified by MS
analysis in the LRR region and two in the Ig domains.
Furthermore, we could demonstrate that hsPxd01 is a
homotrimeric oxidoreductase. This corresponds to the overall
structure of peroxidasin fromD.melanogaster reported byNel-
son et al. in 1994 (4). Analyses ofmolarmasses of the full-length
protein (504 kDa) and truncated versions under oxidized and
reduced conditions clearly demonstrated that hsPxd01 is a
homotrimeric protein having the protomers covalently bound
via (redox-sensitive) cystine bridges at their C-terminal VWC
domains. One might speculate whether this trimeric structure
of hsPxd01 is related to the fact that type IV collagen before
post-translational modification is also a (hetero)trimeric pro-
tein. Peroxidasin 1 has been reported to cross-link these triple-
helical protomers into oligomers. In detail, during this process
hsPxd01 should be responsible for cross-linking two opposing
C-terminal NC1 trimers of collagen IV to form a hexameric
dimer (13). This collagen “knot” (covalent sulfilimine bonds
between Met-93 and Lys-211 at the interface of adjoining
protomers) is synthesized by hsPxd01 by the release of hypo-
bromous acid (15). To allow such a specific reaction, a close
interaction between the three-armed hsPxd01 and the C ter-
mini of the collagen IV protomers must occur. Furthermore, a
close proximity between the enzyme and NC1 protomers
reduces the oxidative damage by hindering accidental scaveng-
ing of hypobromous acid by other residues. One might specu-
late whether the additional domains (LRR and Ig domains)
mediate a suitable distance and orientation by protein-protein
interactions.
Compared with myeloperoxidase (40) and lactoperoxidase
(41), human peroxidasin 1 shows several intermediate states
during temperature-mediated unfolding. This reflects the
multidomain architecture of this peculiar peroxidase but also
suggests a noncooperative unfolding pathway that might indi-
cate loose interaction between the individual domains. This
flexibility could support the interaction of hsPxd01 with the
protomers of trimeric collagen IV as described above.
Based on the homology with the human peroxidases and the
fact that those efficientlymediate the two-electron oxidation of
halides, it was speculated that hsPxd01 also catalyzes the for-
mation of hypohalous acids. The available data from the litera-
ture are puzzling and mostly based on end-point determina-
tions after long incubation of hsPxd01 with halides and
FIGURE 7. Thermal stability of human peroxidasin 1. A, temperature-mediated unfolding of hsPxd01 followed by ECD spectroscopy at 208 nm. The
corresponding fit is depicted in gray. B, temperature-mediated unfolding of hsPxd01 followed by ECD spectroscopy at 412 nm. The corresponding fit is
depicted in gray. Temperature-mediated unfolding of hsPxd01 (C) and hsPxd01-con4 (D) followed by differential scanning calorimetry. Original DSC data are
depicted in black. Fitting of data (red lines) suggests the occurrence of four consecutive unfolding events. The correspondingmidterm transition temperatures
(Tm values) are depicted.
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hydrogen peroxide (12, 13, 15). In this study, for the first time
the steady-state kinetics of bromide oxidation at physiological
pH 7.4 was examined. Oxidation of chloride (140mM) at pH 7.4
was negligible (data not shown), which is closely related to the
hierarchy of the reduction potential of the Fe(III)/Fe(II) couple
(i.e. hsPxd01 	 LPO 	 EPO 		 MPO) and the fact that
hsPxd01 as well as LPO or EPO are not able to form the elec-
tron-withdrawing sulfonium ion heme to protein linkage. The
latter is typical for MPO and its strong oxidation capacity (42–
44). However, bromide oxidation by hsPxd01 and hsPxd01-
con4 could be monitored continuously and shown to depend
on both the hydrogen peroxide as well as the bromide concen-
tration (Fig. 8). This (for the first time) allowed us to determine
apparent enzymatic parameters. Interestingly, the KMapp values
for bromide were similar for both hsPxd01 (4.1 mM) and
hsPxd01-con4 (4.4 mM), which reflects the similar spectral and
redox properties (and thus heme cavity architecture) for both
proteins. Nevertheless, compared with mammalian peroxi-
dases, the apparent catalytic efficiency of bromide oxidation by
hsPxd01 is relatively low. Based on the same assay, the apparent
catalytic efficiency of bromide oxidation of hsPxd01-con4 is
only about 1% comparedwithMPO (32). Butmost interestingly
FIGURE 8.Rate ofNADHbromohydrin formationbyhumanperoxidasin 1. 100 nM enzyme full-length hsPxd01 (E) or the construct hsPxd01-con4 (F) were
incubated at 25 °C in 20mM phosphate buffer, pH 7.4, containing 100M NADHwith either 50M H2O2 with varying concentrations of NaBr (A) or 5 mM NaBr
with varying concentrations of H2O2 (B). The formation of bromohydrin was detected by absorbance at 275 nm, and initial rates were determined within the
first 1 min. Data showmeans of triplicates.
TABLE 3
Kinetic parameters for the formationofNADHbromohydrinby recombinanthumanperoxidasin 1 (hsPxd01) and the construct hsPxd01-con4 in
100mM phosphate buffer, pH 7.4, and 25 °C
hsPxd01 hsPxd01-con4
H2O2
KMapp 18.6
 4.6 M KMapp 37.7
 6.0 M
Vmaxapp 0.12
 0.01 M min1 Vmaxapp 2.2
 0.5 M min1
kcat 1.2 min1 kcat 22 min1
kcat/KMapp 6.5 104 M1min1 kcat/KMapp 5.8 105 M1min1
Br
KMapp 4.1
 0.5 mM KMapp 4.4
 0.8 mM
Vmaxapp 0.21
 0.01 M min1 Vmaxapp 3.4
 0.2 M min1
kcat 2.1 min1 kcat 34 min1
kcat/KMapp 5.1 102 M1min1 kcat/KMapp 7.7 103 M1min1
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(despite the fact that it binds bromide with the same affinity),
the full-length enzyme is even less active. This discrepancy is
surprising at first sight but could be related to the physiological
role of hsPxd01 described above. In contrast to the human per-
oxidases, which are involved in the innate immune system and
release antimicrobial hypohalous acids at high flux, such an
uncontrolled reactivity would be deleterious for a biosynthetic
oxidation of distinct (hydroxyl)lysine and methionine residues.
Because there is no x-ray structure of neither full-length
hsPxd01 nor a truncated version so far available, one can only
speculate about necessary conformational changes that occur
upon binding of hsPxd01 to collagen IV thereby increasing the
accessibility of the heme cavity. Most probably the structural
differences between monomeric hsPxd01-con4 and trimeric
full-length hsPxd01 are related to substrate accessibility rather
than differences in the heme cavity.
Clearly more studies are necessary to probe this hypothesis.
Together with TPO (45), peroxidasins represent peroxidases
that are not primarily related with defense of the mature orga-
nism (like LPO, EPO, and MPO that release freely diffusing
hypohalous acids) butwith biosynthetic tasks. In both cases, the
target proteins (thyroglobulin and collagen IV) are not able to
enter the active site but will be modified specifically by mobile
oxidants (hypoiodous acid and hypobromous acid). Under-
standing theses reactions at a molecular level will be a great
challenge in the future.
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